ACOR   $0.6132  -29.52% Market Closed

Acorda Therapeutics Inc
Total Cash 29.98M
totalCashPerShare 24.136
EBITDA 8.40M
Total Debt 190.90M
quickRatio 0.208
currentRatio 0.328
Total Revenue 117.63M
debtToEquity
Revenue/Share 94.713
ROA -0.05768
ROE
grossProfits
freeCashflow 20.14M
operatingCashflow -13.98M
earningsGrowth
revenueGrowth 0.207
grossMargins 0.82628
ebitdaMargins 0.07143
operatingMargins 0.03899
profitMargins -2.14952
enterpriseValue 161.45M
forwardPE
floatShares 1.22M
sharesOutstanding 1.24M
sharesShort 8.10K
sharesShortPriorMonth 11.08K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.13%
Short Ratio help_outline 1.84%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue -127.169
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -252.85M
trailingEps -203.57%
forwardEps -0.96%
enterpriseToEbitda 19.21
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 23
lastUpdated April 17, 2024, 10:22 a.m.